Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

[1] Jemal A(2010)Cancer statistics CA: a cancer journal for clinicians 60 277-300

[2] Siegel R(1999)Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1-7

[3] Xu J(2007)Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial Jama 297 267-277

[4] Ward E(2006)Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer Cochrane Database Syst Rev 3 CD002093-504

[5] Sener SF(1984)Pharmacologic rationale for regional drug delivery J Clin Oncol 2 498-632

[6] Fremgen A(1958)Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit Ann Surg 148 616-4201

[7] Menck HR(2006)Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020 J Clin Oncol 24 4196-590

[8] Winchester DP(1999)Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP) Ann Surg Oncol 6 582-1007

[9] Oettle H(2001)Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol 19 1001-154

[10] Post S(2005)Leptomeningeal metastasis Cancer Invest 23 145-498

[1] Jemal A(2010)Cancer statistics CA: a cancer journal for clinicians 60 277-300

[2] Siegel R(1999)Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1-7

[3] Xu J(2007)Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial Jama 297 267-277

[4] Ward E(2006)Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer Cochrane Database Syst Rev 3 CD002093-504

[5] Sener SF(1984)Pharmacologic rationale for regional drug delivery J Clin Oncol 2 498-632

[6] Fremgen A(1958)Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit Ann Surg 148 616-4201

[7] Menck HR(2006)Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020 J Clin Oncol 24 4196-590

[8] Winchester DP(1999)Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP) Ann Surg Oncol 6 582-1007

[9] Oettle H(2001)Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol 19 1001-154

[10] Post S(2005)Leptomeningeal metastasis Cancer Invest 23 145-498